Fatal liver failure associated with pioglitazone

British Medical Journal

Volumn 329, Issue 7463, 2004, Pages 429-

  Farley Hills, Ed ^a   Sivasankar, R ^a   Martin, M ^a  

^a YSBYTY GWYNEDD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CEPHALOSPORIN; GLICLAZIDE; LERCANIDIPINE; PIOGLITAZONE; ROSIGLITAZONE; TROGLITAZONE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANAMNESIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD ANALYSIS; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; LIVER FAILURE; LIVER TOXICITY; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; SHORT SURVEY; ULTRASOUND;

EID: 4344572776     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.329.7463.429     Document Type: Short Survey

References (4)

1. Isley WL. Hepatotoxicity of thiazolidinediones. Expert Opin Drug Saf 2003;2:581-6.
2. Tolman KG, Chandramouli J. Hepatotoxicity of the thiazolidinediones. Clin Liver Dis 2003;7:369-79.
3. Scheen AJ. Hepatotoxicity with thiazolidinediones: is it a class effect? Drug Saf 2001;24:873-88.
4. Chase MP, Yarze JC. Pioglitazone-associated fulminant hepatic failure. Am J Gastroenterol 2002;97:502-3.